Stay updated on Betalutin in Relapsed/Refractory Non-Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Betalutin in Relapsed/Refractory Non-Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Betalutin in Relapsed/Refractory Non-Hodgkin Lymphoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0. The study page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T13:24:23.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    A site-wide NIH notice appears above the page, linking to updates and FAQs about the transition from “Artificial Intelligence” to “Super Intelligence” terminology.
    Difference
    1%
    Check dated 2026-10-24T13:04:54.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The site footer revision label changes from v3.7.1 to v3.7.2 while the study page remains unavailable with a 403 error.
    Difference
    0.2%
    Check dated 2026-10-17T13:14:39.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1; the page remains a 403 error page.
    Difference
    0.2%
    Check dated 2026-10-10T12:54:56.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The page now loads a 403 Forbidden error page, replacing the previous study record content. As a result, the detailed study information and related sections are no longer accessible.
    Difference
    20%
    Check dated 2026-09-19T19:25:19.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Revision: v3.6.6 replaces the previous Revision: v3.6.5 on the page, indicating a small update to the page’s metadata/UI.
    Difference
    0.0%
    Check dated 2026-08-29T20:26:57.000Z thumbnail image

Stay in the know with updates to Betalutin in Relapsed/Refractory Non-Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Betalutin in Relapsed/Refractory Non-Hodgkin Lymphoma Clinical Trial page.